Compare stocks

Financière de Tubize SA is a Belgian holding company established in 1928, serving as the reference shareholder of UCB, a global biopharmaceutical company. Its sole investment is a significant stake in UCB, focusing on long-term value creation through active participation in UCB's strategic decisions. Headquartered in Brussels, Belgium, the company embodies strong family and entrepreneurial values, uniting descendants of UCB's founder, Emmanuel Janssen, and like-minded investors. This strategic positioning provides UCB with the stability necessary for sustained growth and investment in new products for patients with serious illnesses.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.